Clinical Trial Using Proteomics Technologies for Personalized Medicine Approach to Breast Cancer

The trial is using technologies from Caris Life Sciences and George Mason University's Center for Applied Proteomics and Molecular Medicine to create proteomic profiles to determine which therapies work best for each individual patient.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories